
Elli Peselev
Examiner (ID: 18809)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1803, 1211, 1203, 1802, 1621, 1623, 2899 |
| Total Applications | 2819 |
| Issued Applications | 1829 |
| Pending Applications | 143 |
| Abandoned Applications | 853 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 817144
[patent_doc_number] => 07410952
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-12
[patent_title] => 'Derivatives of azithromycin'
[patent_app_type] => utility
[patent_app_number] => 10/552318
[patent_app_country] => US
[patent_app_date] => 2004-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2999
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/410/07410952.pdf
[firstpage_image] =>[orig_patent_app_number] => 10552318
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/552318 | Derivatives of azithromycin | Apr 15, 2004 | Issued |
Array
(
[id] => 7466384
[patent_doc_number] => 20040198715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Methods of administering dalbavancin for treatment of skin and soft tissue infections'
[patent_app_type] => new
[patent_app_number] => 10/828483
[patent_app_country] => US
[patent_app_date] => 2004-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 23215
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198715.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828483
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828483 | Methods of administering dalbavancin for treatment of skin and soft tissue infections | Apr 15, 2004 | Abandoned |
Array
(
[id] => 7605365
[patent_doc_number] => 07115564
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-03
[patent_title] => 'Stable pharmaceutical compositions of dalbavancin and methods of administration'
[patent_app_type] => utility
[patent_app_number] => 10/828439
[patent_app_country] => US
[patent_app_date] => 2004-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22979
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115564.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828439
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828439 | Stable pharmaceutical compositions of dalbavancin and methods of administration | Apr 15, 2004 | Issued |
Array
(
[id] => 7377859
[patent_doc_number] => 20040220122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Methods of administering dalbavancin for treatment of bacterial infections'
[patent_app_type] => new
[patent_app_number] => 10/828379
[patent_app_country] => US
[patent_app_date] => 2004-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 23219
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220122.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828379
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828379 | Methods of administering dalbavancin for treatment of bacterial infections | Apr 15, 2004 | Abandoned |
Array
(
[id] => 7346662
[patent_doc_number] => 20040192622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Stabilized azithromycin compositions'
[patent_app_type] => new
[patent_app_number] => 10/822773
[patent_app_country] => US
[patent_app_date] => 2004-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8589
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192622.pdf
[firstpage_image] =>[orig_patent_app_number] => 10822773
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/822773 | Stabilized azithromycin compositions | Apr 12, 2004 | Abandoned |
Array
(
[id] => 7264966
[patent_doc_number] => 20040242502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Semi-synthetic saponin analogs with carrier and immune stimulatory activities for DNA and RNA vaccines'
[patent_app_type] => new
[patent_app_number] => 10/820036
[patent_app_country] => US
[patent_app_date] => 2004-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15937
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242502.pdf
[firstpage_image] =>[orig_patent_app_number] => 10820036
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/820036 | Semi-synthetic saponin analogs with carrier and immune stimulatory activities for DNA and RNA vaccines | Apr 7, 2004 | Abandoned |
Array
(
[id] => 5096155
[patent_doc_number] => 20070117764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Compositions comprising macrolide t-cell immunomodulators or immunosuppressants in combination with antibacterials'
[patent_app_type] => utility
[patent_app_number] => 10/550359
[patent_app_country] => US
[patent_app_date] => 2004-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3530
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20070117764.pdf
[firstpage_image] =>[orig_patent_app_number] => 10550359
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/550359 | Compositions comprising macrolide t-cell immunomodulators or immunosuppressants in combination with antibacterials | Apr 1, 2004 | Abandoned |
Array
(
[id] => 5242882
[patent_doc_number] => 20070021377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Pharmaceutical composition comprising a macrolide immunomodulator'
[patent_app_type] => utility
[patent_app_number] => 10/550356
[patent_app_country] => US
[patent_app_date] => 2004-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3344
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021377.pdf
[firstpage_image] =>[orig_patent_app_number] => 10550356
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/550356 | Pharmaceutical composition comprising a macrolide immunomodulator | Apr 1, 2004 | Abandoned |
| 10/816376 | ETHANOLATE OF AZITHROMYCIN, PROCESS FOR MANUFACTURE, AND PHARMACEUTICAL COMPOSITIONS THEREOF | Apr 1, 2004 | Abandoned |
Array
(
[id] => 7434339
[patent_doc_number] => 20040266699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Flavonoid compounds capable of modifying the dynamic and/or physical state of biological membranes and to stimulate the endogenous synthesis of stress proteins in eukaryotic cells, relative synthesis and their use'
[patent_app_type] => new
[patent_app_number] => 10/491612
[patent_app_country] => US
[patent_app_date] => 2004-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7212
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266699.pdf
[firstpage_image] =>[orig_patent_app_number] => 10491612
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/491612 | Flavonoid compounds capable of modifying the dynamic and/or physical state of biological membranes and to stimulate the endogenous synthesis of stress proteins in eukaryotic cells, relative synthesis and their use | Apr 1, 2004 | Abandoned |
Array
(
[id] => 5000361
[patent_doc_number] => 20070042995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Use of acetyl-d-aminoglycosamine in treatment of local lesions and systematic symptoms related to infections of virus or bacteria'
[patent_app_type] => utility
[patent_app_number] => 10/550784
[patent_app_country] => US
[patent_app_date] => 2004-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2098
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20070042995.pdf
[firstpage_image] =>[orig_patent_app_number] => 10550784
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/550784 | Use of acetyl-d-aminoglycosamine in treatment of local lesions and systematic symptoms related to infections of virus or bacteria | Mar 28, 2004 | Abandoned |
Array
(
[id] => 7672937
[patent_doc_number] => 20040180842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => '4\"-substituted-9-deoxo-9A-AZA-9A-homoerythromycin a derivatives'
[patent_app_type] => new
[patent_app_number] => 10/810922
[patent_app_country] => US
[patent_app_date] => 2004-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17623
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180842.pdf
[firstpage_image] =>[orig_patent_app_number] => 10810922
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/810922 | 4″-substituted-9-deoxo-9a-aza-9a-homoerythromycin A derivatives | Mar 25, 2004 | Issued |
Array
(
[id] => 7437765
[patent_doc_number] => 20040266997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Degradation products of azithromycin, and methods for their indentification'
[patent_app_type] => new
[patent_app_number] => 10/809065
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4421
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266997.pdf
[firstpage_image] =>[orig_patent_app_number] => 10809065
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/809065 | Degradation products of azithromycin, and methods for their indentification | Mar 24, 2004 | Abandoned |
Array
(
[id] => 7276329
[patent_doc_number] => 20040235780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Pharmaceutical composition of antiviral agents'
[patent_app_type] => new
[patent_app_number] => 10/809250
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7662
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235780.pdf
[firstpage_image] =>[orig_patent_app_number] => 10809250
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/809250 | Pharmaceutical composition of antiviral agents | Mar 24, 2004 | Abandoned |
Array
(
[id] => 7351395
[patent_doc_number] => 20040248824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Method for controlling beetles'
[patent_app_type] => new
[patent_app_number] => 10/490587
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8395
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248824.pdf
[firstpage_image] =>[orig_patent_app_number] => 10490587
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/490587 | Method for controlling beetles | Mar 24, 2004 | Abandoned |
Array
(
[id] => 6959341
[patent_doc_number] => 20050215519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products'
[patent_app_type] => utility
[patent_app_number] => 10/808409
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12521
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20050215519.pdf
[firstpage_image] =>[orig_patent_app_number] => 10808409
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/808409 | Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products | Mar 24, 2004 | Abandoned |
Array
(
[id] => 7329833
[patent_doc_number] => 20040254126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => '11-12 Bicyclic erythromycin derivatives'
[patent_app_type] => new
[patent_app_number] => 10/806748
[patent_app_country] => US
[patent_app_date] => 2004-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45122
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254126.pdf
[firstpage_image] =>[orig_patent_app_number] => 10806748
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/806748 | 11-12 Bicyclic erythromycin derivatives | Mar 22, 2004 | Abandoned |
Array
(
[id] => 628309
[patent_doc_number] => RE039383
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2006-11-07
[patent_title] => 'Process for 6-O-alkylation of erythromycin derivatives'
[patent_app_type] => reissue
[patent_app_number] => 10/806089
[patent_app_country] => US
[patent_app_date] => 2004-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5978
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/039/RE039383.pdf
[firstpage_image] =>[orig_patent_app_number] => 10806089
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/806089 | Process for 6-O-alkylation of erythromycin derivatives | Mar 21, 2004 | Issued |
Array
(
[id] => 554502
[patent_doc_number] => 07160866
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-09
[patent_title] => 'Isolation of tigogenin pentaglycoside from Chlorophytum nimonii'
[patent_app_type] => utility
[patent_app_number] => 10/806065
[patent_app_country] => US
[patent_app_date] => 2004-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4155
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/160/07160866.pdf
[firstpage_image] =>[orig_patent_app_number] => 10806065
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/806065 | Isolation of tigogenin pentaglycoside from Chlorophytum nimonii | Mar 21, 2004 | Issued |
Array
(
[id] => 5678534
[patent_doc_number] => 20060183890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Isopropanolate of azithromycin and method of manufacturing'
[patent_app_type] => utility
[patent_app_number] => 10/550104
[patent_app_country] => US
[patent_app_date] => 2004-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 2197
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183890.pdf
[firstpage_image] =>[orig_patent_app_number] => 10550104
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/550104 | Isopropanolate of azithromycin and method of manufacturing | Mar 18, 2004 | Abandoned |